Cranswick plc (LON:CWK – Get Free Report) insider Christopher Aldersley bought 3 shares of the company’s stock in a transaction on Monday, September 21st. The shares were acquired at an average price of GBX 5,129 per share, with a total value of £153.87.
Christopher Aldersley also recently made the following trade(s):
- On Friday, August 21st, Christopher Aldersley acquired 3 shares of Cranswick stock. The shares were acquired at an average cost of £5,350 per share, with a total value of £16,050.
- On Tuesday, July 21st, Christopher Aldersley acquired 2 shares of Cranswick stock. The shares were bought at an average price of GBX 5,415 per share, with a total value of £108.30.
Cranswick Price Performance
LON:CWK traded down GBX 80 during trading hours on Wednesday, reaching GBX 5,080. 203,832 shares of the company traded hands, compared to its average volume of 519,768. The stock has a market cap of £2.72 billion, a P/E ratio of 17.51, a P/E/G ratio of 2.62 and a beta of 0.55. The firm’s 50-day moving average is GBX 5,294.07 and its 200-day moving average is GBX 5,351.90. Cranswick plc has a 1-year low of GBX 4,805 and a 1-year high of GBX 5,810. The company has a debt-to-equity ratio of 23.26, a current ratio of 1.76 and a quick ratio of 1.02.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on CWK
About Cranswick
Cranswick is a leading and innovative supplier of premium, fresh and added-value food products with revenues of c. £3.0 billion. The business employs over 16,000 people and operates from 23 well-invested, highly efficient facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high-quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food.
Featured Stories
- Five stocks we like better than Cranswick
- Quantum and Rare Earths? Implications of the Pasqal/USAR Partnership
- Lockheed’s Stock Hasn’t Priced In Its Own Backlog—Boeing’s Might Already Have
- Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
- Old Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom
Receive News & Ratings for Cranswick Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cranswick and related companies with MarketBeat.com's FREE daily email newsletter.
